Consistent with preclinical studies, Furukawa et al. reported increased IL-4 levels in the CSF of ALS patients compared to controls, as well as a negative correlation between IL-4 levels and disease progression in ALS patients [50]. This evidence concerns the gene IL4 and amyotrophic lateral sclerosis.